Viewing Study NCT06517134



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06517134
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-19

Brief Title: Prescribing Patterns of Antihypertensive Drugs in Uncomplicated Hypertension
Sponsor: None
Organization: None

Study Overview

Official Title: Association Between GP Characteristics and Prescription Patterns for Antihypertensive Drugs A Cross-sectional Study in Normandy France
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypertension incurs substantial cardiovascular morbidity and mortality particularly in primary prevention settings General practitioners GPs play a pivotal role in the management of hypertension in primary care yet variations exist among GPs The determinants shaping GPs antihypertensive medication AD prescription patterns in the setting of hypertension remain ambiguous This investigation sought to elucidate how GPs characteristics and professional activities influence AD prescriptions A cross-sectional study utilizing a sample of 2165 GPs was conducted in Normandy France in 2019 The ratio of AD prescriptions to overall prescription volume was computed for each practitioner GPs were classified as low or high AD prescribers based on the median of this ratio The ratio was examined in relation to GPs demographic and professional variables such as age gender practice setting years of experience consultation frequency the demographics and socioeconomic status of their patient panels and prevalence of chronic conditions in patients These associations were explored using both univariate and multivariate analyses
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None